MJ Venture’s Post

🌏 Have you considered Australia for your next trial? Here is why Australia is a Top Destination for Medical Device Clinical Studies #Australia presents an attractive and efficient option for MedTech innovators looking to streamline clinical development. Whether you're a start-up or an established player, the benefits of running trials there can give your device a head start on the path to commercialization. Here’s why: ✅ Fast Regulatory Pathway: The TGA’s Clinical Trial Notification (CTN) scheme allows trials to begin without formal pre-approval, significantly reducing startup timelines. ✅ Cost-Effective R&D Incentives: Companies can claim up to 43.5% cashback on eligible expenses through Australia’s R&D tax rebate, maximizing budgets. ✅ Global Data Recognition: Clinical data from Australian trials is accepted by regulators like the FDA and EMA, enabling seamless market progression. ✅ Diverse Patient Recruitment: Australia’s multicultural population ensures robust, generalizable trial data. ✅ World-Class Research Infrastructure: With cutting-edge facilities and renowned investigators, Australian trials maintain high scientific standards. You can catch up with Deborah Bell this week at AusBiotech or set up a consultation at a more convenient time to explore how Australia can support your clinical development goals. #MedTech #ClinicalTrials #MedicalDevices #Australia #ClinicalResearch #Innovation

Our team's article on the Veterans Affairs formulary management process was published in Life Science Leader in July 2024. Key takeaways include the highly centralized nature of the VA formulary and the importance of considering both national criteria-for-use and local-level prior authorizations when developing a strategy for this market. https://lnkd.in/e_-_BptP

From the rise of specialized clinical logistics environments to the need for increased collaboration across ecosystem partners, Mark Patterson and Fernanda Teles recap some of the key highlights of a very engaging panel discussion at the 25th Annual Clinical Trial Supply Europe 2024 Conference. Explore these highlights here: https://okt.to/rfH84w #OCTMedDevice #CTSEurope #ClinicalTrials #ClinicalLogistics #Healthcare #Pharma #biotechnology

Discover the key takeaways from a stimulating panel discussion at the 25th Annual Clinical Trial Supply Europe 2024 Conference by @Mark and @Fernanda. Dive into the recap here: https://okt.to/ODHZ2f #OCTMedDevice #CTSEurope #ClinicalTrials #ClinicalLogistics #Healthcare #Pharma #biotechnology

From the rise of specialized clinical logistics environments to the need for increased collaboration across ecosystem partners, Mark Patterson and Fernanda Teles recap some of the key highlights of a very engaging panel discussion at the 25th Annual Clinical Trial Supply Europe 2024 Conference. Explore these highlights here: https://okt.to/Lkuwn3 #OCTMedDevice #CTSEurope #ClinicalTrials #ClinicalLogistics #Healthcare #Pharma #biotechnology

From the rise of specialized clinical logistics environments to the need for increased collaboration across ecosystem partners, Mark Patterson and Fernanda Teles recap some of the key highlights of a very engaging panel discussion at the 25th Annual Clinical Trial Supply Europe 2024 Conference. Explore these highlights here: https://okt.to/Wn1ebh #OCTMedDevice #CTSEurope #ClinicalTrials #ClinicalLogistics #Healthcare #Pharma #biotechnology

From the rise of specialized clinical logistics environments to the need for increased collaboration across ecosystem partners, Mark Patterson and Fernanda Teles recap some of the key highlights of a very engaging panel discussion at the 25th Annual Clinical Trial Supply Europe 2024 Conference. Explore these highlights here: https://okt.to/0CwtgO #OCTMedDevice #CTSEurope #ClinicalTrials #ClinicalLogistics #Healthcare #Pharma #biotechnology

If you are a pharmaceutical company or biotech running clinical trials, have you thought about how genomic data can be used to make them cheaper, quicker and more efficient? From identifying people who respond better to therapeutics to saving failed clinical trials through retrospective analyses, genomic information -- harnessed through Polygenic Risk Scores (PRS) -- have a clear role to play in the future of pharmaceutical developments. Read more in Allelica, Inc's article on how PRS can super-power your clinical trials and get in touch with us to learn more about how our tools can help you perform better clinical trials, whatever stage your trial might be at. #polygenicriskscores #pharma #genomics https://lnkd.in/e9UfEg2k

From the rise of specialized clinical logistics environments to the need for increased collaboration across ecosystem partners, Mark Patterson and Fernanda Teles recap some of the key highlights of a very engaging panel discussion at the 25th Annual Clinical Trial Supply Europe 2024 Conference. Explore these highlights here: https://okt.to/76ZIpt #OCTMedDevice #CTSEurope #ClinicalTrials #ClinicalLogistics #Healthcare #Pharma #biotechnology

From the rise of specialized clinical logistics environments to the need for increased collaboration across ecosystem partners, Mark Patterson and Fernanda Teles recap some of the key highlights of a very engaging panel discussion at the 25th Annual Clinical Trial Supply Europe 2024 Conference. Explore these highlights here: https://okt.to/RuSvZT #OCTMedDevice #CTSEurope #ClinicalTrials #ClinicalLogistics #Healthcare #Pharma #biotechnology